Clinical Research

Clinical Trials Drug Development Randomized Controlled Trials Drug Efficacy Studies Drug Trials Patient Outcomes Observational Studies Patient Studies Translational Medicine

Lilly Plans Q1 2027 U.S. Filing for Retatrutide After Two More Positive Phase 3 Trials

Regulators will weigh a reported cardiovascular safety signal during Lilly's manufacturing verification.

argenx Posts $1.52 Billion Quarter as VYVGART Readouts Loom

Large Study Links Several Artificial Sweeteners to Faster Cognitive Decline

Study Finds Small Increase in Optic‑Nerve Injury With GLP‑1 Diabetes Drugs

Stem-Cell Dopamine Grafts Found Feasible and Safe at One Year in Parkinson’s Trial

Even Mild COVID Can Cause Measurable Long‑Term Eye Damage, Study Finds

Human‑Safe Drug Restores Neuronal DNA Repair in Mouse Model of Alzheimer’s

First Randomized Trial Finds Ketogenic Diet Improves Metabolic Markers and Shows Early Psychiatric Signals in Psychotic Disorders

Minor Heart Dysfunction Predicts Microscopic Brain Damage in Memory Regions

Covid Boosters Elicit Antibodies That Neutralise Some Bat and Pangolin Coronaviruses

Blocking IL‑6 Cuts Compulsive Drinking in Female Mice

Study Finds Common GLP‑1 Use and Misuse Among People With Eating Disorders

Chip-Based Metasurface Detects Traumatic Brain Injury Biomarkers at Femtogram Levels

GLP‑1 Drugs Move into the Mainstream as UK Clears Oral Wegovy and Tirzepatide Shows Bigger Weight Loss

Algae-Based Microrobots Greatly Increase Chemotherapy Delivery to Bladder Tumors

Vibrating Pill Predicts Relapse Risk in Anorexia Patients

Moderna Restructures Leadership as It Prepares for Multiple Vaccine Launches

Updated COVID Vaccine Linked to Lower Risk of Major Heart Events in Large VA Study

AI‑Driven Deep Brain Stimulation Improves Gait in Parkinson’s Patients

Tirzepatide Raises Imaging Signals of Brown Adipose Tissue in Small Randomized Trial